top of page


What Is Eppe (Efpeglenatide)? South Korea’s New GLP-1 Weight Loss Drug Explained
The global GLP-1 revolution in obesity medicine, driven by Wegovy, Mounjaro, and their accelerating successors, has largely been a story written in the United States, Denmark, and the European Union. That story now has a new chapter, and it begins in Seoul. In October 2026, Hanmi Pharmaceutical became the first Korean company to win regulatory approval for a domestically developed GLP-1 receptor agonist for obesity. The drug is called Eppe, its active ingredient is efpeglenat

Jan Medical Group
Nov 410 min read


This Weight Loss Drug Helped Oprah Winfrey Break Her 7-lb-a-year Holiday Weight Gain
In a candid revelation that resonates with the struggles of countless individuals around the globe, Oprah Winfrey has shared her personal...

Pauleen Flake, RND
Mar 27, 20243 min read
bottom of page
